D
PetMed Express, Inc.
PETS
$4.19
$0.020.48%
D
Sell
6/12/2023Downgrade
PetMed Express, Inc. (PETS) was downgraded to D from D+ on 6/12/2023 due to a decline in the volatility index and total return index.
PetMed Express, Inc. (PETS) was downgraded to D from D+ on 6/12/2023 due to a decline in the volatility index and total return index.
D
Sell
5/25/2023Upgraded
PetMed Express, Inc. (PETS) was upgraded to D+ from D on 5/25/2023 due to an increase in the efficiency index and growth index. Total revenue increased 6.01% from $58.87M to $62.41M.
PetMed Express, Inc. (PETS) was upgraded to D+ from D on 5/25/2023 due to an increase in the efficiency index and growth index. Total revenue increased 6.01% from $58.87M to $62.41M.
D
Sell
5/22/2023Downgrade
PetMed Express, Inc. (PETS) was downgraded to D from D+ on 5/22/2023 due to a decline in the total return index, valuation index and growth index. EBIT declined 106.92% from $3.33M to -$230, earnings per share declined from $0.1273 to -$0.0009, and total revenue declined 9.98% from $65.39M to $58.87M.
PetMed Express, Inc. (PETS) was downgraded to D from D+ on 5/22/2023 due to a decline in the total return index, valuation index and growth index. EBIT declined 106.92% from $3.33M to -$230, earnings per share declined from $0.1273 to -$0.0009, and total revenue declined 9.98% from $65.39M to $58.87M.
D
Sell
10/27/2022Downgrade
PetMed Express, Inc. (PETS) was downgraded to D+ from C- on 10/27/2022 due to a decline in the growth index, volatility index and total return index. Earnings per share declined from $0.3001 to $0.1373, EBIT declined 50.55% from $7.06M to $3.49M, and operating cash flow declined 26.81% from $8.72M to $6.38M.
PetMed Express, Inc. (PETS) was downgraded to D+ from C- on 10/27/2022 due to a decline in the growth index, volatility index and total return index. Earnings per share declined from $0.3001 to $0.1373, EBIT declined 50.55% from $7.06M to $3.49M, and operating cash flow declined 26.81% from $8.72M to $6.38M.
C
Hold
7/22/2022Downgrade
PetMed Express, Inc. (PETS) was downgraded to C- from C on 7/22/2022 due to a decline in the volatility index, valuation index and dividend index.
PetMed Express, Inc. (PETS) was downgraded to C- from C on 7/22/2022 due to a decline in the volatility index, valuation index and dividend index.
C
Hold
5/25/2022Upgraded
PetMed Express, Inc. (PETS) was upgraded to C from C- on 5/25/2022 due to a noticeable increase in the growth index, volatility index and solvency index. Earnings per share increased from $0.21 to $0.3001, EBIT increased 37.11% from $5.15M to $7.06M, and total revenue increased 8.7% from $60.72M to $66M.
PetMed Express, Inc. (PETS) was upgraded to C from C- on 5/25/2022 due to a noticeable increase in the growth index, volatility index and solvency index. Earnings per share increased from $0.21 to $0.3001, EBIT increased 37.11% from $5.15M to $7.06M, and total revenue increased 8.7% from $60.72M to $66M.
C
Hold
5/13/2022Downgrade
PetMed Express, Inc. (PETS) was downgraded to C- from C on 5/13/2022 due to a decline in the total return index and volatility index.
PetMed Express, Inc. (PETS) was downgraded to C- from C on 5/13/2022 due to a decline in the total return index and volatility index.
C
Hold
3/30/2022Upgraded
PetMed Express, Inc. (PETS) was upgraded to C from C- on 3/30/2022 due to an increase in the volatility index and total return index.
PetMed Express, Inc. (PETS) was upgraded to C from C- on 3/30/2022 due to an increase in the volatility index and total return index.
C
Hold
3/15/2022Downgrade
PetMed Express, Inc. (PETS) was downgraded to C- from C on 3/15/2022 due to a decline in the volatility index, valuation index and dividend index.
PetMed Express, Inc. (PETS) was downgraded to C- from C on 3/15/2022 due to a decline in the volatility index, valuation index and dividend index.
C
Hold
2/24/2022Upgraded
PetMed Express, Inc. (PETS) was upgraded to C from C- on 2/24/2022 due to an increase in the volatility index.
PetMed Express, Inc. (PETS) was upgraded to C from C- on 2/24/2022 due to an increase in the volatility index.
C
Hold
2/7/2022Downgrade
PetMed Express, Inc. (PETS) was downgraded to C- from C on 2/7/2022 due to a decline in the growth index, valuation index and total return index. EBIT declined 36.35% from $8.09M to $5.15M, earnings per share declined from $0.31 to $0.21, and total revenue declined 9.9% from $67.39M to $60.72M.
PetMed Express, Inc. (PETS) was downgraded to C- from C on 2/7/2022 due to a decline in the growth index, valuation index and total return index. EBIT declined 36.35% from $8.09M to $5.15M, earnings per share declined from $0.31 to $0.21, and total revenue declined 9.9% from $67.39M to $60.72M.
C
Hold
11/3/2021Upgraded
PetMed Express, Inc. (PETS) was upgraded to C from C- on 11/3/2021 due to an increase in the volatility index and total return index.
PetMed Express, Inc. (PETS) was upgraded to C from C- on 11/3/2021 due to an increase in the volatility index and total return index.
C
Hold
9/23/2021Downgrade
PetMed Express, Inc. (PETS) was downgraded to C- from C on 9/23/2021 due to a decline in the volatility index and total return index.
PetMed Express, Inc. (PETS) was downgraded to C- from C on 9/23/2021 due to a decline in the volatility index and total return index.
C
Hold
8/2/2021Downgrade
PetMed Express, Inc. (PETS) was downgraded to C from C+ on 8/2/2021 due to a significant decline in the growth index, valuation index and solvency index. Operating cash flow declined 102.29% from $18.45M to -$422, earnings per share declined from $0.3389 to $0.22, and EBIT declined 26.84% from $8.39M to $6.14M.
PetMed Express, Inc. (PETS) was downgraded to C from C+ on 8/2/2021 due to a significant decline in the growth index, valuation index and solvency index. Operating cash flow declined 102.29% from $18.45M to -$422, earnings per share declined from $0.3389 to $0.22, and EBIT declined 26.84% from $8.39M to $6.14M.
C
Hold
7/16/2021Upgraded
PetMed Express, Inc. (PETS) was upgraded to C+ from C on 7/16/2021 due to an increase in the valuation index, dividend index and volatility index.
PetMed Express, Inc. (PETS) was upgraded to C+ from C on 7/16/2021 due to an increase in the valuation index, dividend index and volatility index.
C
Hold
6/10/2021Downgrade
PetMed Express, Inc. (PETS) was downgraded to C from C+ on 6/10/2021 due to a decline in the valuation index, total return index and dividend index.
PetMed Express, Inc. (PETS) was downgraded to C from C+ on 6/10/2021 due to a decline in the valuation index, total return index and dividend index.
C
Hold
5/3/2021Upgraded
PetMed Express, Inc. (PETS) was upgraded to C+ from C on 5/3/2021 due to an increase in the valuation index, dividend index and volatility index.
PetMed Express, Inc. (PETS) was upgraded to C+ from C on 5/3/2021 due to an increase in the valuation index, dividend index and volatility index.
C
Hold
1/28/2021Downgrade
PetMed Express, Inc. (PETS) was downgraded to C from C+ on 1/28/2021 due to a large decline in the growth index, valuation index and dividend index. Operating cash flow declined 75.6% from $26.39M to $6.44M, total revenue declined 12.65% from $75.44M to $65.9M, and EBIT declined 11.25% from $10.47M to $9.29M.
PetMed Express, Inc. (PETS) was downgraded to C from C+ on 1/28/2021 due to a large decline in the growth index, valuation index and dividend index. Operating cash flow declined 75.6% from $26.39M to $6.44M, total revenue declined 12.65% from $75.44M to $65.9M, and EBIT declined 11.25% from $10.47M to $9.29M.
C
Hold
1/26/2021Upgraded
PetMed Express, Inc. (PETS) was upgraded to C+ from C on 1/26/2021 due to an increase in the volatility index and total return index.
PetMed Express, Inc. (PETS) was upgraded to C+ from C on 1/26/2021 due to an increase in the volatility index and total return index.
C
Hold
1/4/2021Downgrade
PetMed Express, Inc. (PETS) was downgraded to C from C+ on 1/4/2021 due to a decline in the volatility index, valuation index and dividend index.
PetMed Express, Inc. (PETS) was downgraded to C from C+ on 1/4/2021 due to a decline in the volatility index, valuation index and dividend index.
C
Hold
12/18/2020Upgraded
PetMed Express, Inc. (PETS) was upgraded to C+ from C on 12/18/2020 due to an increase in the total return index and volatility index.
PetMed Express, Inc. (PETS) was upgraded to C+ from C on 12/18/2020 due to an increase in the total return index and volatility index.
C
Hold
11/9/2020Downgrade
PetMed Express, Inc. (PETS) was downgraded to C from C+ on 11/9/2020 due to a decline in the volatility index, growth index and total return index. Total revenue declined 21.59% from $96.2M to $75.44M.
PetMed Express, Inc. (PETS) was downgraded to C from C+ on 11/9/2020 due to a decline in the volatility index, growth index and total return index. Total revenue declined 21.59% from $96.2M to $75.44M.
C
Hold
10/22/2020Upgraded
PetMed Express, Inc. (PETS) was upgraded to C+ from C on 10/22/2020 due to an increase in the volatility index and growth index.
PetMed Express, Inc. (PETS) was upgraded to C+ from C on 10/22/2020 due to an increase in the volatility index and growth index.
C
Hold
10/1/2020Downgrade
PetMed Express, Inc. (PETS) was downgraded to C from C+ on 10/1/2020 due to a decline in the volatility index and total return index.
PetMed Express, Inc. (PETS) was downgraded to C from C+ on 10/1/2020 due to a decline in the volatility index and total return index.
C
Hold
8/6/2020Upgraded
PetMed Express, Inc. (PETS) was upgraded to C+ from C on 8/6/2020 due to a noticeable increase in the growth index, valuation index and volatility index. Total revenue increased 29.5% from $74.29M to $96.2M, earnings per share increased from $0.35 to $0.3887, and EBIT increased 10.84% from $8.51M to $9.44M.
PetMed Express, Inc. (PETS) was upgraded to C+ from C on 8/6/2020 due to a noticeable increase in the growth index, valuation index and volatility index. Total revenue increased 29.5% from $74.29M to $96.2M, earnings per share increased from $0.35 to $0.3887, and EBIT increased 10.84% from $8.51M to $9.44M.
C
Hold
8/4/2020Downgrade
PetMed Express, Inc. (PETS) was downgraded to C from C+ on 8/4/2020 due to a decline in the total return index.
PetMed Express, Inc. (PETS) was downgraded to C from C+ on 8/4/2020 due to a decline in the total return index.
C
Hold
7/20/2020Upgraded
PetMed Express, Inc. (PETS) was upgraded to C+ from C on 7/20/2020 due to an increase in the total return index and volatility index.
PetMed Express, Inc. (PETS) was upgraded to C+ from C on 7/20/2020 due to an increase in the total return index and volatility index.
C
Hold
7/2/2020Downgrade
PetMed Express, Inc. (PETS) was downgraded to C from C+ on 7/2/2020 due to a decline in the valuation index, total return index and dividend index.
PetMed Express, Inc. (PETS) was downgraded to C from C+ on 7/2/2020 due to a decline in the valuation index, total return index and dividend index.
C
Hold
4/3/2020Upgraded
PetMed Express, Inc. (PETS) was upgraded to C+ from C on 4/3/2020 due to a significant increase in the total return index, growth index and volatility index. Earnings per share increased from $0.33 to $0.34.
PetMed Express, Inc. (PETS) was upgraded to C+ from C on 4/3/2020 due to a significant increase in the total return index, growth index and volatility index. Earnings per share increased from $0.33 to $0.34.
C
Hold
10/21/2019Upgraded
PetMed Express, Inc. (PETS) was upgraded to C from C- on 10/21/2019 due to an increase in the volatility index.
PetMed Express, Inc. (PETS) was upgraded to C from C- on 10/21/2019 due to an increase in the volatility index.
C
Hold
7/1/2019Downgrade
PetMed Express, Inc. (PETS) was downgraded to C- from C on 7/1/2019 due to a noticeable decline in the total return index, volatility index and growth index. EBIT declined 17.13% from $9.41M to $7.8M, and earnings per share declined from $0.38 to $0.3201.
PetMed Express, Inc. (PETS) was downgraded to C- from C on 7/1/2019 due to a noticeable decline in the total return index, volatility index and growth index. EBIT declined 17.13% from $9.41M to $7.8M, and earnings per share declined from $0.38 to $0.3201.
C
Hold
1/22/2019Downgrade
PetMed Express, Inc. (PETS) was downgraded to C from C+ on 1/22/2019 due to a large decline in the growth index, volatility index and total return index. Operating cash flow declined 107.41% from $22.03M to -$1.63M, total revenue declined 18.3% from $87.39M to $71.4M, and EBIT declined 16.21% from $15.76M to $13.2M.
PetMed Express, Inc. (PETS) was downgraded to C from C+ on 1/22/2019 due to a large decline in the growth index, volatility index and total return index. Operating cash flow declined 107.41% from $22.03M to -$1.63M, total revenue declined 18.3% from $87.39M to $71.4M, and EBIT declined 16.21% from $15.76M to $13.2M.
C
Hold
10/10/2018Downgrade
PetMed Express, Inc. (PETS) was downgraded to C+ from B- on 10/10/2018 due to a decline in the volatility index and total return index.
PetMed Express, Inc. (PETS) was downgraded to C+ from B- on 10/10/2018 due to a decline in the volatility index and total return index.
B
Buy
8/17/2018Downgrade
PetMed Express, Inc. (PETS) was downgraded to B- from B on 8/17/2018 due to a decline in the total return index, valuation index and dividend index.
PetMed Express, Inc. (PETS) was downgraded to B- from B on 8/17/2018 due to a decline in the total return index, valuation index and dividend index.
B
Buy
8/2/2018Upgraded
PetMed Express, Inc. (PETS) was upgraded to B from B- on 8/2/2018 due to a significant increase in the growth index, valuation index and total return index. Operating cash flow increased 886.3% from $2.23M to $22.03M, total revenue increased 29.81% from $67.32M to $87.39M, and earnings per share increased from $0.49 to $0.6165.
PetMed Express, Inc. (PETS) was upgraded to B from B- on 8/2/2018 due to a significant increase in the growth index, valuation index and total return index. Operating cash flow increased 886.3% from $2.23M to $22.03M, total revenue increased 29.81% from $67.32M to $87.39M, and earnings per share increased from $0.49 to $0.6165.
B
Buy
6/5/2018Downgrade
PetMed Express, Inc. (PETS) was downgraded to B- from B on 6/5/2018 due to a substantial decline in the growth index, total return index and volatility index. Operating cash flow declined 86.74% from $16.84M to $2.23M.
PetMed Express, Inc. (PETS) was downgraded to B- from B on 6/5/2018 due to a substantial decline in the growth index, total return index and volatility index. Operating cash flow declined 86.74% from $16.84M to $2.23M.
B
Buy
3/26/2018Downgrade
PetMed Express, Inc. (PETS) was downgraded to B from B+ on 3/26/2018 due to a noticeable decline in the total return index and volatility index.
PetMed Express, Inc. (PETS) was downgraded to B from B+ on 3/26/2018 due to a noticeable decline in the total return index and volatility index.
B
Buy
1/31/2018Upgraded
PetMed Express, Inc. (PETS) was upgraded to B+ from B on 1/31/2018 due to a substantial increase in the total return index and solvency index. The quick ratio increased from 2.75 to 3.66.
PetMed Express, Inc. (PETS) was upgraded to B+ from B on 1/31/2018 due to a substantial increase in the total return index and solvency index. The quick ratio increased from 2.75 to 3.66.
B
Buy
11/1/2017Downgrade
PetMed Express, Inc. (PETS) was downgraded to B from B+ on 11/1/2017 due to a substantial decline in the total return index and volatility index.
PetMed Express, Inc. (PETS) was downgraded to B from B+ on 11/1/2017 due to a substantial decline in the total return index and volatility index.
B
Buy
8/23/2017Downgrade
PetMed Express, Inc. (PETS) was downgraded to B+ from A- on 8/23/2017 due to a decline in the volatility index.
PetMed Express, Inc. (PETS) was downgraded to B+ from A- on 8/23/2017 due to a decline in the volatility index.
A
Buy
8/2/2017Upgraded
PetMed Express, Inc. (PETS) was upgraded to A- from B+ on 8/2/2017 due to an increase in the valuation index, growth index and solvency index. Total revenue increased 26.38% from $63.03M to $79.66M, EBIT increased 23.25% from $11.7M to $14.42M, and earnings per share increased from $0.3699 to $0.45.
PetMed Express, Inc. (PETS) was upgraded to A- from B+ on 8/2/2017 due to an increase in the valuation index, growth index and solvency index. Total revenue increased 26.38% from $63.03M to $79.66M, EBIT increased 23.25% from $11.7M to $14.42M, and earnings per share increased from $0.3699 to $0.45.
B
Buy
7/26/2017Downgrade
PetMed Express, Inc. (PETS) was downgraded to B+ from A- on 7/26/2017 due to a decline in the valuation index and dividend index.
PetMed Express, Inc. (PETS) was downgraded to B+ from A- on 7/26/2017 due to a decline in the valuation index and dividend index.
A
Buy
7/11/2017Upgraded
PetMed Express, Inc. (PETS) was upgraded to A- from B+ on 7/11/2017 due to an increase in the total return index.
PetMed Express, Inc. (PETS) was upgraded to A- from B+ on 7/11/2017 due to an increase in the total return index.
B
Buy
6/22/2017Downgrade
PetMed Express, Inc. (PETS) was downgraded to B+ from A- on 6/22/2017 due to a decline in the valuation index and dividend index.
PetMed Express, Inc. (PETS) was downgraded to B+ from A- on 6/22/2017 due to a decline in the valuation index and dividend index.
A
Buy
6/9/2017Downgrade
PetMed Express, Inc. (PETS) was downgraded to A- from A on 6/9/2017 due to a decline in the total return index and valuation index.
PetMed Express, Inc. (PETS) was downgraded to A- from A on 6/9/2017 due to a decline in the total return index and valuation index.
A
Buy
5/25/2017Upgraded
PetMed Express, Inc. (PETS) was upgraded to A from B+ on 5/25/2017 due to a substantial increase in the total return index, growth index and solvency index. Operating cash flow increased 303.47% from $3.86M to $15.56M, earnings per share increased from $0.2381 to $0.3699, and EBIT increased 52.8% from $7.66M to $11.7M.
PetMed Express, Inc. (PETS) was upgraded to A from B+ on 5/25/2017 due to a substantial increase in the total return index, growth index and solvency index. Operating cash flow increased 303.47% from $3.86M to $15.56M, earnings per share increased from $0.2381 to $0.3699, and EBIT increased 52.8% from $7.66M to $11.7M.
B
Buy
5/10/2017Upgraded
PetMed Express, Inc. (PETS) was upgraded to B+ from B on 5/10/2017 due to an increase in the total return index.
PetMed Express, Inc. (PETS) was upgraded to B+ from B on 5/10/2017 due to an increase in the total return index.
B
Buy
4/17/2017Downgrade
PetMed Express, Inc. (PETS) was downgraded to B from B+ on 4/17/2017 due to a decline in the valuation index, volatility index and dividend index.
PetMed Express, Inc. (PETS) was downgraded to B from B+ on 4/17/2017 due to a decline in the valuation index, volatility index and dividend index.
B
Buy
3/24/2017Upgraded
PetMed Express, Inc. (PETS) was upgraded to B+ from B on 3/24/2017 due to an increase in the valuation index and volatility index.
PetMed Express, Inc. (PETS) was upgraded to B+ from B on 3/24/2017 due to an increase in the valuation index and volatility index.
B
Buy
3/9/2017Downgrade
PetMed Express, Inc. (PETS) was downgraded to B from B+ on 3/9/2017 due to a noticeable decline in the total return index and volatility index.
PetMed Express, Inc. (PETS) was downgraded to B from B+ on 3/9/2017 due to a noticeable decline in the total return index and volatility index.
B
Buy
2/24/2017Downgrade
PetMed Express, Inc. (PETS) was downgraded to B+ from A- on 2/24/2017 due to a major decline in the total return index.
PetMed Express, Inc. (PETS) was downgraded to B+ from A- on 2/24/2017 due to a major decline in the total return index.
A
Buy
2/3/2017Downgrade
PetMed Express, Inc. (PETS) was downgraded to A- from A on 2/3/2017 due to a large decline in the total return index and growth index. Operating cash flow declined 73.72% from $14.68M to $3.86M, total revenue declined 13.04% from $60.79M to $52.87M, and EBIT declined 0.98% from $7.73M to $7.66M.
PetMed Express, Inc. (PETS) was downgraded to A- from A on 2/3/2017 due to a large decline in the total return index and growth index. Operating cash flow declined 73.72% from $14.68M to $3.86M, total revenue declined 13.04% from $60.79M to $52.87M, and EBIT declined 0.98% from $7.73M to $7.66M.
A
Buy
1/23/2017Upgraded
PetMed Express, Inc. (PETS) was upgraded to A from B+ on 1/23/2017 due to a noticeable increase in the volatility index, valuation index and dividend index.
PetMed Express, Inc. (PETS) was upgraded to A from B+ on 1/23/2017 due to a noticeable increase in the volatility index, valuation index and dividend index.
B
Buy
12/27/2016Upgraded
PetMed Express, Inc. (PETS) was upgraded to B+ from B on 12/27/2016 due to a major increase in the total return index, volatility index and solvency index. The quick ratio increased from 3.45 to 6.22.
PetMed Express, Inc. (PETS) was upgraded to B+ from B on 12/27/2016 due to a major increase in the total return index, volatility index and solvency index. The quick ratio increased from 3.45 to 6.22.
B
Buy
11/1/2016Downgrade
PetMed Express, Inc. (PETS) was downgraded to B from B+ on 11/1/2016 due to a decline in the total return index and volatility index.
PetMed Express, Inc. (PETS) was downgraded to B from B+ on 11/1/2016 due to a decline in the total return index and volatility index.
B
Buy
10/17/2016Upgraded
PetMed Express, Inc. (PETS) was upgraded to B+ from B on 10/17/2016 due to an increase in the volatility index.
PetMed Express, Inc. (PETS) was upgraded to B+ from B on 10/17/2016 due to an increase in the volatility index.
B
Buy
9/19/2016Downgrade
PetMed Express, Inc. (PETS) was downgraded to B from B+ on 9/19/2016 due to a decline in the total return index and volatility index.
PetMed Express, Inc. (PETS) was downgraded to B from B+ on 9/19/2016 due to a decline in the total return index and volatility index.
B
Buy
8/3/2016Upgraded
PetMed Express, Inc. (PETS) was upgraded to B+ from B on 8/3/2016 due to a major increase in the total return index, growth index and solvency index. Operating cash flow increased 928.45% from -$1.58M to $13.11M, total revenue increased 30.86% from $55.39M to $72.49M, and EBIT increased 21.14% from $8.59M to $10.4M.
PetMed Express, Inc. (PETS) was upgraded to B+ from B on 8/3/2016 due to a major increase in the total return index, growth index and solvency index. Operating cash flow increased 928.45% from -$1.58M to $13.11M, total revenue increased 30.86% from $55.39M to $72.49M, and EBIT increased 21.14% from $8.59M to $10.4M.
B
Buy
3/11/2016Downgrade
PetMed Express, Inc. (PETS) was downgraded to B from B+ on 3/11/2016 due to a decline in the volatility index and total return index.
PetMed Express, Inc. (PETS) was downgraded to B from B+ on 3/11/2016 due to a decline in the volatility index and total return index.
B
Buy
2/4/2016Downgrade
PetMed Express, Inc. (PETS) was downgraded to B+ from A- on 2/4/2016 due to a noticeable decline in the volatility index, valuation index and dividend index.
PetMed Express, Inc. (PETS) was downgraded to B+ from A- on 2/4/2016 due to a noticeable decline in the volatility index, valuation index and dividend index.
A
Buy
1/21/2016Upgraded
PetMed Express, Inc. (PETS) was upgraded to A- from B on 1/21/2016 due to a noticeable increase in the volatility index and total return index.
PetMed Express, Inc. (PETS) was upgraded to A- from B on 1/21/2016 due to a noticeable increase in the volatility index and total return index.
B
Buy
1/13/2016Downgrade
PetMed Express, Inc. (PETS) was downgraded to B from B+ on 1/13/2016 due to a decline in the volatility index and valuation index.
PetMed Express, Inc. (PETS) was downgraded to B from B+ on 1/13/2016 due to a decline in the volatility index and valuation index.
B
Buy
12/24/2015Upgraded
PetMed Express, Inc. (PETS) was upgraded to B+ from B on 12/24/2015 due to an increase in the volatility index and valuation index.
PetMed Express, Inc. (PETS) was upgraded to B+ from B on 12/24/2015 due to an increase in the volatility index and valuation index.
B
Buy
12/9/2015Downgrade
PetMed Express, Inc. (PETS) was downgraded to B from B+ on 12/9/2015 due to a noticeable decline in the volatility index and valuation index.
PetMed Express, Inc. (PETS) was downgraded to B from B+ on 12/9/2015 due to a noticeable decline in the volatility index and valuation index.
B
Buy
11/9/2015Downgrade
PetMed Express, Inc. (PETS) was downgraded to B+ from A- on 11/9/2015 due to a decline in the growth index and total return index. Operating cash flow declined 70.12% from $10.81M to $3.23M, earnings per share declined from $0.2868 to $0.22, and EBIT declined 22.01% from $9.09M to $7.09M.
PetMed Express, Inc. (PETS) was downgraded to B+ from A- on 11/9/2015 due to a decline in the growth index and total return index. Operating cash flow declined 70.12% from $10.81M to $3.23M, earnings per share declined from $0.2868 to $0.22, and EBIT declined 22.01% from $9.09M to $7.09M.
A
Buy
5/22/2015Upgraded
PetMed Express, Inc. (PETS) was upgraded to A- from B+ on 5/22/2015 due to an increase in the growth index, valuation index and solvency index. Earnings per share increased from $0.2394 to $0.247, EBIT increased 2% from $7.67M to $7.82M, and total revenue increased 1.44% from $49.28M to $49.99M.
PetMed Express, Inc. (PETS) was upgraded to A- from B+ on 5/22/2015 due to an increase in the growth index, valuation index and solvency index. Earnings per share increased from $0.2394 to $0.247, EBIT increased 2% from $7.67M to $7.82M, and total revenue increased 1.44% from $49.28M to $49.99M.
B
Buy
5/13/2015Downgrade
PetMed Express, Inc. (PETS) was downgraded to B+ from A- on 5/13/2015 due to a decline in the total return index and volatility index.
PetMed Express, Inc. (PETS) was downgraded to B+ from A- on 5/13/2015 due to a decline in the total return index and volatility index.
A
Buy
4/28/2015Upgraded
PetMed Express, Inc. (PETS) was upgraded to A- from B+ on 4/28/2015 due to an increase in the volatility index and total return index.
PetMed Express, Inc. (PETS) was upgraded to A- from B+ on 4/28/2015 due to an increase in the volatility index and total return index.
B
Buy
4/13/2015Downgrade
PetMed Express, Inc. (PETS) was downgraded to B+ from A- on 4/13/2015 due to a decline in the volatility index, valuation index and dividend index.
PetMed Express, Inc. (PETS) was downgraded to B+ from A- on 4/13/2015 due to a decline in the volatility index, valuation index and dividend index.
A
Buy
3/23/2015Upgraded
PetMed Express, Inc. (PETS) was upgraded to A- from B+ on 3/23/2015 due to a noticeable increase in the total return index and volatility index.
PetMed Express, Inc. (PETS) was upgraded to A- from B+ on 3/23/2015 due to a noticeable increase in the total return index and volatility index.
B
Buy
3/2/2015Upgraded
PetMed Express, Inc. (PETS) was upgraded to B+ from B on 3/2/2015 due to a significant increase in the growth index, volatility index and total return index. Earnings per share increased from $0.1365 to $0.2394, and EBIT increased 27.68% from $6M to $7.67M.
PetMed Express, Inc. (PETS) was upgraded to B+ from B on 3/2/2015 due to a significant increase in the growth index, volatility index and total return index. Earnings per share increased from $0.1365 to $0.2394, and EBIT increased 27.68% from $6M to $7.67M.
B
Buy
1/20/2015Upgraded
PetMed Express, Inc. (PETS) was upgraded to B from B- on 1/20/2015 due to an increase in the volatility index.
PetMed Express, Inc. (PETS) was upgraded to B from B- on 1/20/2015 due to an increase in the volatility index.
B
Buy
10/31/2014Downgrade
PetMed Express, Inc. (PETS) was downgraded to B- from B on 10/31/2014 due to a substantial decline in the growth index and valuation index. Earnings per share declined from $0.2491 to $0.1365, operating cash flow declined 34.54% from $14.26M to $9.33M, and EBIT declined 23.91% from $7.89M to $6M.
PetMed Express, Inc. (PETS) was downgraded to B- from B on 10/31/2014 due to a substantial decline in the growth index and valuation index. Earnings per share declined from $0.2491 to $0.1365, operating cash flow declined 34.54% from $14.26M to $9.33M, and EBIT declined 23.91% from $7.89M to $6M.
B
Buy
7/2/2014Upgraded
PetMed Express, Inc. (PETS) was upgraded to B from B- on 7/2/2014 due to an increase in the total return index, valuation index and volatility index.
PetMed Express, Inc. (PETS) was upgraded to B from B- on 7/2/2014 due to an increase in the total return index, valuation index and volatility index.
B
Buy
6/17/2014Downgrade
PetMed Express, Inc. (PETS) was downgraded to B- from B on 6/17/2014 due to a noticeable decline in the total return index, valuation index and efficiency index. Net income declined 0.33% from $4.54M to $4.53M.
PetMed Express, Inc. (PETS) was downgraded to B- from B on 6/17/2014 due to a noticeable decline in the total return index, valuation index and efficiency index. Net income declined 0.33% from $4.54M to $4.53M.
NASDAQ
03/07/2025 4:00PM Eastern
Quotes delayed
